Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors (Q38342094)

2 September 2017

1 reference

title

Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors (English)

1 reference

2 September 2017

1 reference

Philip Seeman

1 reference

2 September 2017

publication date

3 February 2015

1 reference

2 September 2017

1 reference

2 September 2017

1 reference

2 September 2017

1 reference

2 September 2017

page(s)

183-189

1 reference

Continuous dopaminergic stimulation--from theory to clinical practice

2 September 2017

cites work

1 reference

Impulse control disorders in Chinese Parkinson's disease patients: the effect of ergot derived dopamine agonist

21 January 2018

1 reference

Prospective cohort study of impulse control disorders in Parkinson's disease.

21 January 2018

1 reference

N-0923, a selective dopamine D2 receptor agonist, is efficacious in rat and monkey models of Parkinson's disease

21 January 2018

1 reference

The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride.

21 January 2018

1 reference

Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease

21 January 2018

1 reference

The neurobiology and genetics of impulse control disorders: relationships to drug addictions

21 January 2018

1 reference

Pathological gambling caused by drugs used to treat Parkinson disease

21 January 2018

1 reference

The functional state of the dopamine receptor in the anterior pituitary is in the high affinity form

21 January 2018

1 reference

Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907.

21 January 2018

1 reference

Linking the family of D2 receptors to neuronal circuits in human brain: insights into schizophrenia

21 January 2018

1 reference

The Iowa Gambling Task and the three fallacies of dopamine in gambling disorder

21 January 2018

1 reference

Dopaminergic inhibition of adenylate cyclase correlates with high affinity agonist binding to anterior pituitary D2 dopamine receptors

21 January 2018

1 reference

Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors

21 January 2018

1 reference

Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes

21 January 2018

1 reference

Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment?

21 January 2018

1 reference

Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs

21 January 2018

1 reference

The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson's disease

21 January 2018

1 reference

Autoradiographic evidence for the occlusion of rat brain dopamine D3 receptors in vivo

21 January 2018

1 reference

Antiparkinson therapeutic potencies correlate with their affinities at dopamine D2(High) receptors.

21 January 2018

1 reference

All Roads to Schizophrenia Lead to Dopamine Supersensitivity and Elevated Dopamine D2High Receptors

21 January 2018

1 reference

Deriving the therapeutic concentrations for clozapine and haloperidol: the apparent dissociation constant of a neuroleptic at the dopamine D2 or D4 receptor varies with the affinity of the competing radioligand.

21 January 2018

1 reference

Antiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptors

21 January 2018

1 reference

Dopamine D2 and D3 receptors in human putamen, caudate nucleus, and globus pallidus

21 January 2018

1 reference

Psychosis pathways converge via D2high dopamine receptors

21 January 2018

1 reference

Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor

21 January 2018

1 reference

Decreases in dopamine receptors but not in dopamine transporters in alcoholics

21 January 2018

1 reference

21 January 2018

1 reference

Association of dopamine agonist use with impulse control disorders in Parkinson disease

21 January 2018

1 reference

Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients

21 January 2018

1 reference

Pramipexole modulates the neural network of reward anticipation.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/SYN.21805

1 reference

2 September 2017

1 reference